甲基二甲基碳酸盐-铜复合物通过NKG2D-NKG2DL轴点燃瘤微环境
Daciana C Dumut1,2, Marian Hajduch3,4, Amanda M Zacharias5
1Department of Experimental Medicine, Faculty of Medicine, McGill University, Montreal, QC, Canada.
Frontiers in immunology
|February 27, 2025
概括
双乙二甲酸盐 (CuET) 将免疫冷的结直肠癌 (CRC) 转化为免疫热的瘤. 这种新型化合物增强了抗瘤免疫反应,促进了淋巴细胞的活动,并改善了大多数CRC患者的结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 具有缺陷DNA不匹配修复 (MMR-d) 的晚期转移性结肠直肠癌 (CRC) 显示出比MMR-proficient (MMR-p) 的CRC更好的结果.
- 大多数CRC (95%) 是MMR专业的,并且具有较低的免疫原性,称为"免疫感冒"瘤.
- 开发提高免疫感冒瘤免疫性质的策略对于改善患者的治疗结果至关重要.
研究的目的:
- 调查 bis-diethyldithiocarbamate (CuET) 对结直肠癌瘤微环境 (TME) 的影响.
- 评估CuET的潜力,将免疫不活跃的 ('冷') 瘤转化为活跃的 ('热') 瘤.
- 阐明CuET作为CRC中的免疫调节剂的作用机制.
主要方法:
- 用新型化合物CuET治疗结直肠癌模型.
- 评估瘤微环境的变化,包括淋巴细胞透和细胞毒性.
- 通过NKG2D/NKG2DL轴评估自然杀手 (NK) 和T细胞活性和瘤细胞识别.
- 在体内研究以确定CuET的安全性和有效性.
主要成果:
- CuET有效地将免疫不活跃的瘤转化为"热"的瘤.
- 观察到淋巴细胞透率增加和NK和T细胞细胞毒性增加.
- 由NKG2D/NKG2DL轴介导的淋巴细胞增强了非自我识别.
- CuET表现出强大的抗癌细胞毒性,在体内已证实安全性和有效性.
结论:
- CuET作为一种强大的免疫调节剂,转化结直肠癌的TME.
- CuET增强NK和T细胞的细胞毒性,并增强瘤细胞的识别能力.
- 这项研究揭示了CuET在将"冷"瘤转化为"热"的新机制,为CRC提供了一个有前途的治疗策略.
更多相关视频
08:26MAME Models for 4D Live-cell Imaging of Tumor: Microenvironment Interactions that Impact Malignant Progression
Published on: February 17, 2012
14.4K
08:52Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
Published on: January 19, 2018
13.8K
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
147
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
